25,203NRG1

Shui Xiang1, Yiwen Zheng2, Mengxiao Wang3

  • 1Department of Cardiothoracic Surgery, Liuzhou Worker's Hospital, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, Guangxi, China.

PubMed
概括

在0.2%的实体瘤中发现NRG1融合,CD74是最常见的合作伙伴. 患有NRG1融合的患者可能会从向治疗中受益,扩大各种癌症的治疗选择.